Skip to results
Modify your search
NARROW
1-20 of 36
Authors: Mark D Russell
Journal Article
ACCEPTED MANUSCRIPT
Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study Open Access
Rheumatology, keaf233, https://doi.org/10.1093/rheumatology/keaf233
Published: 05 May 2025
Journal Article
OA03 Increasing biologic and targeted synthetic DMARD use across multiple therapeutic indications in England: a population-level study Free
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.003, https://doi.org/10.1093/rheumatology/keaf142.003
Published: 28 April 2025
Journal Article
P004 Temporal and regional variation in the initiation of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study Free
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.046, https://doi.org/10.1093/rheumatology/keaf142.046
Published: 28 April 2025
Journal Article
Abatacept and the risk of malignancy: a meta-analysis across disease indications Open Access
Rheumatology, keaf114, https://doi.org/10.1093/rheumatology/keaf114
Published: 24 February 2025
Journal Article
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study Open Access
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2432–2441, https://doi.org/10.1093/rheumatology/keae607
Published: 01 November 2024
Journal Article
Association between interleukin-12 p40 subunit and risk of primary Sjögren’s disease: a Mendelian randomization study Get access
Rheumatology, Volume 64, Issue 4, April 2025, Pages 2295–2299, https://doi.org/10.1093/rheumatology/keae475
Published: 02 September 2024
Journal Article
Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study Get access
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2479–2486, https://doi.org/10.1093/rheumatology/keae305
Published: 04 June 2024
Journal Article
P086 Trends in the Incidence and Management of Gout in England: A Nationwide Study using the OpenSAFELY Platform Free
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.127, https://doi.org/10.1093/rheumatology/keae163.127
Published: 24 April 2024
Journal Article
OA06 Regional differences in work productivity in patients with early rheumatoid arthritis in England and Wales Free
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.006, https://doi.org/10.1093/rheumatology/keae163.006
Published: 24 April 2024
Journal Article
P085 Implementing treat-to-target urate-lowering therapy during hospitalisations for gout flares: a prospective cohort study Free
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.126, https://doi.org/10.1093/rheumatology/keae163.126
Published: 24 April 2024
Journal Article
OA39 The influence of safety warnings on the prescribing of JAK inhibitors in England: an interrupted time-series analysis Free
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.039, https://doi.org/10.1093/rheumatology/keae163.039
Published: 24 April 2024
Journal Article
P062 Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach Free
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.103, https://doi.org/10.1093/rheumatology/keae163.103
Published: 24 April 2024
Journal Article
Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares Open Access
Rheumatology, Volume 63, Issue 8, August 2024, Pages 2222–2229, https://doi.org/10.1093/rheumatology/kead574
Published: 31 October 2023
Journal Article
Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit Open Access
Rheumatology, Volume 63, Issue 7, July 2024, Pages 1856–1867, https://doi.org/10.1093/rheumatology/kead484
Published: 19 September 2023
Journal Article
British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine Open Access
Rheumatology, Volume 63, Issue 2, February 2024, Pages e37–e38, https://doi.org/10.1093/rheumatology/kead384
Published: 31 July 2023
Journal Article
OA08 JAK inhibitors and the risk of malignancy: a meta-analysis across licenced disease indications Free
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.008, https://doi.org/10.1093/rheumatology/kead104.008
Published: 24 April 2023
Journal Article
OA19 Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY Free
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.019, https://doi.org/10.1093/rheumatology/kead104.019
Published: 24 April 2023
Journal Article
COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort Open Access
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2979–2988, https://doi.org/10.1093/rheumatology/kead018
Published: 16 January 2023
Journal Article
Diagnosing Camurati–Engelmann disease—the age of whole-exome sequencing Open Access
Rheumatology, Volume 62, Issue 7, July 2023, Pages e221–e222, https://doi.org/10.1093/rheumatology/keac670
Published: 15 December 2022
Journal Article
Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England Open Access
Rheumatology, Volume 62, Issue 7, July 2023, Pages 2426–2434, https://doi.org/10.1093/rheumatology/keac638
Published: 10 November 2022
